Absci Corporation (NASDAQ:ABSI) Q4 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Absci Corporation fourth quarter and full year 2025 business update conference call.
Absci Corp (ABSI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 12,550,799 | $43,802,289 | +4% | 0.29% |
| 2. | Redmile Group Jeremy Green | 8,253,316 | $28,804,073 | 2.12% | |
| 3. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 2,349,725 | $8,200,538 | 0.04% | |
| 4. | Woodline Partners Michael Rockefeller And Karl Kroeker | 2,280,783 | $7,959,933 | +29% | 0.03% |
| 5. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,134,803 | $7,450,462 | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.29 | 100,000 | $229,000.00 | 421,446 | 2026-03-12 | Filing | |
| $2.74 | 75,095 | $205,760.30 | 189,055 | 2026-02-27 | Filing | |
| $3.72 | 40,000 | $148,800.00 | 63,320 | 2025-12-05 | Filing | |
| $2.66 | 95,785 | $254,788.10 | 113,960 | 2025-09-22 | Filing | |
| $2.70 | 10,000 | $27,000.00 | 180,428 | 2025-09-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.99 | 26,761 | $80,015.39 | 8,334,567 | 2026-02-02 | Filing | |
| $2.99 | 17,496 | $52,313.04 | 383,538 | 2026-02-02 | Filing | |
| $4.98 | 19,859 | $98,891.86 | 384,751 | 2024-06-13 | Filing | |
| $4.40 | 3,100,000 | $13,640,000.00 | 11,279,522 | 2024-05-22 | Filing | |
| $1.44 | 40,439 | $58,248.34 | 14,379,522 | 2023-11-28 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,547 | $4,641 | 0% | |
| 2. | 173 | $519 | 0% |
News See All
Analysts Cut Absci (ABSI) Target, Spotlight New Alopecia Therapy in Early Trials
Absci Corporation (NASDAQ:ABSI) is one of the best penny stocks to buy in 2026.
10 Best Penny Stocks to Buy for 2026
A rally in large-cap growth stocks was the catalyst behind US equities powering to record highs in 2025.
Absci Unveils Preclinical Data for AI-Designed ABS-201, Targeting a Novel Hormonal Pathway for Hair Loss Treatment
Absci Corporation (NASDAQ:ABSI) is one of the best biotech penny stocks to buy according to analysts.
Absci Corporation (ABSI) Announces First Participants Dosed In Phase 1/2a HEADLINE Trial
Absci Corporation (NASDAQ:ABSI) announced on December 4, 2025, that the first healthy volunteers had been dosed in the Phase 1/2a HEADLINE clinical trial investigating ABS-201, an experimental anti-prolactin...
10 Best Biotech Penny Stocks to Buy According to Analysts
On December 24, Jared Holz of Mizuho joined 'Power Lunch' on CNBC to talk about how to play biotech moving into 2026.
12 Best Genomics Stocks to Invest In
Companies that study DNA to improve people's lives are known as genomics stocks.
Absci Corporation (ABSI) Draws Full Buy Consensus With 150% Upside Potential
Absci Corporation (NASDAQ:ABSI) is among the Best Get Rich Fast Stocks to Buy Right Now.
13 Best Get Rich Fast Stocks to Buy Right Now
In today's fast-paced world, everyone is prioritising investments that have both high and relatively quick returns.
Absci Corporation (NASDAQ:ABSI)’s ABS‑201 Shows Promise in Hair Loss Treatment, Analysts See Upside
Absci Corporation (NASDAQ:ABSI) is one of the best multibagger penny stocks to buy right now.
Hedge Fund Resource Center